Multivalent Tranexamic Acid (TXA) and Benzamidine Derivatives for Serine Protease Inhibition
- PMID: 40567280
- PMCID: PMC12186753
- DOI: 10.1021/acsptsci.5c00030
Multivalent Tranexamic Acid (TXA) and Benzamidine Derivatives for Serine Protease Inhibition
Abstract
Blood coagulation and fibrinolysis pathways involve many serine proteases in a careful equilibrium. Disruption of this hemostatic balance can cause life-threatening thromboembolic and bleeding disorders that require therapeutic intervention. Heterobivalent molecules synthesized with both benzamidine (active site serine protease inhibitor) and tranexamic acid (TXA, kringle/lysine-site inhibitor) of increasing dPEG linker lengths (dPEG4-dPEG36) were synthesized and analyzed for plasmin, thrombin, and tissue plasminogen activator (tPA) inhibition using soluble enzymatic substrates. Linker lengths greater than the active and lysine binding site separation achieved improved inhibition with plasmin and tPA due to multivalent subsite binding effects. Despite TXA being a weak active site inhibitor, homomultivalent TXA (PAMAM8-TXA) demonstrated strong competitive plasmin inhibition (K i = 2.5 ± 1.8 μM) due to the statistical rebinding effect. IC50 values were also determined by assaying on physiologically relevant, fluorescently tagged, annular fibrin clots to capture the effect of kringle binding inhibition on fibrinolytic potential in the presence and absence of inhibitors.
Keywords: benzamidine; enzyme inhibition; multivalency; serine proteases; tranexamic acid.
© 2025 The Authors. Published by American Chemical Society.
Similar articles
-
Tranexamic acid for percutaneous nephrolithotomy.Cochrane Database Syst Rev. 2023 Oct 26;10(10):CD015122. doi: 10.1002/14651858.CD015122.pub2. Cochrane Database Syst Rev. 2023. PMID: 37882229 Free PMC article.
-
Antifibrinolytics for heavy menstrual bleeding.Cochrane Database Syst Rev. 2018 Apr 15;4(4):CD000249. doi: 10.1002/14651858.CD000249.pub2. Cochrane Database Syst Rev. 2018. PMID: 29656433 Free PMC article.
-
Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders.Cochrane Database Syst Rev. 2016 Mar 15;3(3):CD009733. doi: 10.1002/14651858.CD009733.pub3. Cochrane Database Syst Rev. 2016. PMID: 26978005 Free PMC article.
-
Drugs to reduce bleeding and transfusion in major open vascular or endovascular surgery: a systematic review and network meta-analysis.Cochrane Database Syst Rev. 2023 Feb 17;2(2):CD013649. doi: 10.1002/14651858.CD013649.pub2. Cochrane Database Syst Rev. 2023. PMID: 36800489 Free PMC article.
-
Antifibrinolytic drugs for treating primary postpartum haemorrhage.Cochrane Database Syst Rev. 2018 Feb 20;2(2):CD012964. doi: 10.1002/14651858.CD012964. Cochrane Database Syst Rev. 2018. PMID: 29462500 Free PMC article.